IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Proteostasis Therapeutics

CUSIP: HB0000641 | 1 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Broderick Brian C65,000
0.0% of portfolio›$29.5K
StyleTurnoverLocationFiled
Broderick Brian C
65,000$29.5K0.0%GrowthVery LowBoston, MA2026-08-11